Abstract:tuales, tanto generales como específicos de EM, y la segunda como aumento de horas trabajadas. Conclusión Los resultados de los estudios revisados, a pesar de la diversidad de su metodología, sugieren que natalizumab mejora la CV y PL de los pacientes con EM. Palabras clave Natalizumab • Calidad de vida • Esclerosis múltiple • Productividad laboral
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.